Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile

Simple item page
dc.contributor.authorAbu-Arja, Mohammad H.
dc.contributor.authorRojas del Rio, Nicolas
dc.contributor.authorMorales La Madrid, Andres
dc.contributor.authorLassaletta, Alvaro
dc.contributor.authorCoven, Scott L.
dc.contributor.authorMoreno, Rosa
dc.contributor.authorValero, Miguel
dc.contributor.authorPerez, Veronica
dc.contributor.authorEspinoza, Felipe
dc.contributor.authorFernandez, Eduardo
dc.contributor.authorSantander, Jose
dc.contributor.authorTordecilla, Juan
dc.contributor.authorOyarce, Veronica
dc.contributor.authorKopp, Katherine
dc.contributor.authorBartels, Ute
dc.contributor.authorQaddoumi, Ibrahim
dc.contributor.authorFinlay, Jonathan L.
dc.contributor.authorCaceres, Adrian
dc.contributor.authorReyes, Mauricio
dc.contributor.authorEspinoza, Ximena
dc.contributor.authorOsorio, Diana S.
dc.date.accessioned2025-01-20T23:53:49Z
dc.date.available2025-01-20T23:53:49Z
dc.date.issued2021
dc.description.abstractPURPOSE Pediatric neuro-oncology resources are mostly unknown in Chile. We report the human and material resources available in Chilean hospitals providing pediatric neuro-oncology services.
dc.description.abstractMETHODS A cross-sectional survey was distributed to 17 hospitals providing pediatric neuro-oncology services (Programa Infantil Nacional de Drogas Antineopla ' sicas [PINDA] hospitals, 11; private, 6).
dc.description.abstractRESULTS Response rate was 71% (PINDA, 8; private, 4). Pediatric neuro-oncology services were mainly provided within general hospitals (67%). Registries for pediatric CNS tumors and chemotherapy-related toxicities were available in 100% and 67% of hospitals, respectively. CNS tumors were treated by pediatric oncologists in 92% of hospitals; none were formally trained in neuro-oncology. The most used treatment protocols were the national PINDA protocols. All WHO essential medicines for childhood cancer were available in more than 80% of the hospitals except for gemcitabine, oxaliplatin, paclitaxel, and procarbazine. The median number of pediatric neurosurgeons per hospital was two (range, 2-6). General neuroradiologists were available in 83% of the centers. Pathology specimens were sent to neuropathologists (58%), adult pathologists (25%), and pediatric pathologists (17%). Intensity-modulated radiotherapy, conformal radiotherapy, and cobalt radiotherapy were used by 67%, 58%, and 42% of hospitals, respectively. Only one private hospital performed autologous hematopoietic cell transplant for children with CNS tumors.
dc.description.abstractCONCLUSION A wide range of up-to-date treatment modalities are available for children with CNS tumors. Our survey highlights future directions to improve the pediatric neuro-oncology services available in Chile such as the expansion of multidisciplinary clinics, palliative care services, long-term cancer survivorship programs, dedicated clinical research support teams, establishing standardized mechanism for sending pathologic specimen for second opinion to international specialized centers, and establishing specialized neuro-oncology training program. (C) 2021 by American Society of Clinical Oncology
dc.fuente.origenWOS
dc.identifier.doi10.1200/GO.20.00430
dc.identifier.eissn2687-8941
dc.identifier.urihttps://doi.org/10.1200/GO.20.00430
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/94997
dc.identifier.wosidWOS:000835284600004
dc.language.isoen
dc.pagina.final434
dc.pagina.inicio425
dc.revistaJco global oncology
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleEvaluation of the Pediatric Neuro-Oncology Resources Available in Chile
dc.typeartículo
dc.volumen7
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas